Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CERO will decline by -100.00% over the next 2 Weeks and hit $0.00 by Friday, January 2, 2026. In that time frame, CERO's share price is expected to range between $0.00 and $0.20.
BearishAverageBullishCERO shares fell -10.48% in Monday, December 22, 2025's trading session, dropping from a previous close of $0.09 to move at $0.09. The stock demonstrated notable intraday movement (see CERO's key stats for a full breakdown), fluctuating between $0.09 and $0.10, a +14.71% trading range. While recent weeks have seen some volatility, CERO has managed to secure a -19.05% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 146.91K shares changing hands, 41.22K fewer than the previous session. This amounted to $12.49K in total market activity.
Will CERO Continue Its Upward Trend?
According to analyst ratings and projections for CERO, CERo Therapeutics Holdings, Inc. shares are anticipated to increase by +52.87%, potentially reaching $0.18 per share by January 2, 2026. Short-term technical indicators for CERO currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the CERO stock forecast, now is a good time to buy CERO stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on CERO covering social and institutional perspectives.
CERO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CERO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 22.00% to 34.38%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 35.76%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 33.97%, signals a bearish bias in the long-term trend. Insights into CERO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
CERo Therapeutics Short-Term Forecasts
CERO Forecast For Next 5 Days
Our algorithm anticipates CERo Therapeutics (CERO) stock could hit $0.00 by Dec 29, 2025. This represents a -95.88% fall from today's price, following a -95.24% change over the past five days.
CERO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for CERo Therapeutics Holdings, Inc. (CERO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.00, which would mean a -100.00% decrease from the current price of $0.09. Projections for this period range from a high of $0.26 to a low of $0.00.
CERO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for CERo Therapeutics's price over the next three months point to a drop. CERO stock is expected to peak at $230.64 on Mar 06, 2026 before potentially dipping to $0.00 on Mar 20, 2026. On average, CERO is likely to trade around $0.01 in the coming 90 days.
CERo Therapeutics Stock Forecast 2025
Based on our predictive models, CERo Therapeutics (CERO) is expected to trade between $0.00 and $213.40 throughout 2025. This would result in an average price of $0.02, potentially offering investors a -76.47% return from current levels.
CERo Therapeutics Holdings, Inc. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, CERo Therapeutics Holdings, Inc. (CERO) is positioned to show a strong performance in December 2025. The price is predicted to move between $0.00 and $213.40, settling at an average of $0.02. This could translate to a -76.47% loss.
January 2026
Based on current market signals, CERo Therapeutics Holdings, Inc. is projected to trend january 2026. We forecast a trading range from $0.00 to $228.49, with a likely average price of $0.02. Investors could expect a potential return of -76.47%.
February 2026
Our predictive algorithms indicate CERo Therapeutics Holdings, Inc. stock may see a shift in February 2026. The expected range spans $0.00–$218.47, with an average target of $0.01. This represents a cautious outlook and a possible loss of -88.24%.
March 2026
Analyzing established trends, CERo Therapeutics Holdings, Inc. looks set to move in March 2026. Projections place the stock between $0.00 and $230.64, averaging around $0.00. This suggests a -100.00% loss from current levels.
April 2026
Market indicators suggest CERo Therapeutics Holdings, Inc. could experience notable changes during April 2026. Prices could fluctuate within $0.00 to $249.28, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
May 2026
Forecasting for May 2026, models estimate that CERo Therapeutics Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $245.79, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
June 2026
According to our latest forecast models, CERo Therapeutics Holdings, Inc. (CERO) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.00 and $239.61, settling at an average of $0.00. This could translate to a -100.00% loss.
July 2026
Based on current market signals, CERo Therapeutics Holdings, Inc. is projected to trend july 2026. We forecast a trading range from $0.00 to $237.55, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
August 2026
Our predictive algorithms indicate CERo Therapeutics Holdings, Inc. stock may see a shift in August 2026. The expected range spans $0.00–$224.44, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
September 2026
Analyzing established trends, CERo Therapeutics Holdings, Inc. looks set to move in September 2026. Projections place the stock between $0.00 and $228.76, averaging around $0.00. This suggests a -100.00% loss from current levels.
October 2026
Market indicators suggest CERo Therapeutics Holdings, Inc. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $247.87, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
November 2026
Forecasting for November 2026, models estimate that CERo Therapeutics Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $235.19, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
December 2026
According to our latest forecast models, CERo Therapeutics Holdings, Inc. (CERO) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $222.74, settling at an average of $0.00. This could translate to a -100.00% loss.
CERO's history of dividends and stock splits also plays a role in long-term investor confidence.